ArticleCureus2025
Premaxillary Fat Pads on Magnetic Resonance Imaging (MRI) as a Marker of Steroid Side Effects.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Premaxillary fat pads visible on magnetic resonance imaging (MRI) are emerging as a sensitive marker for steroid side effects in chronic diseases including pediatric neuroinflammatory disorders where steroids offer proven efficacy in inflammation control and long-term steroids are the mainstay of treatment. However, their use carries significant risks of systemic toxicity, often presenting as abnormal fat redistribution or growth suppression, which can be challenging to identify clinically, especially in children who are overweight or have subtle physical changes. Through this case report, we highlight that routine follow-up MRI in pediatric neuroinflammatory disorders can serve a dual purpose-not only monitoring disease resolution but also acting as a sensitive tool for the early detection of premaxillary fat pad hypertrophy as an indicator of steroid toxicity. Leveraging MRI's superior soft tissue contrast and decreased radiation exposure, such assessments enable objective and timely quantification of steroid-induced changes, facilitating prompt diagnosis and optimal management, particularly in cases where clinical features are subtle or masked.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.